Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells

References

• LetchfordKBurtHA review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomesEur J Pharm Biopharm200765325926917196803
   PubMed Web of Science ®Google Scholar
• YangYQZhengLSGuoXDQianYZhangLJpH-sensitive micelles self-assembled from amphiphilic copolymer brush for delivery of poorly water-soluble drugsBiomacromolecules201012111612221121600
   PubMed Web of Science ®Google Scholar
• PourcelleVDevougeSGarinotMPreatVMarchand-BrynaertJPCL-PEG-based nanoparticles grafted with GRGDS peptide: preparation and surface analysis by XPSBiomacromolecules20078123977398318039005
   PubMed Web of Science ®Google Scholar
• SonajeKItaliaJLSharmaGBhardwajVTikooKKumarMNDevelopment of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in ratsPharm Res200724589990817377747
   PubMed Web of Science ®Google Scholar
• GarinotMFievezVPourcelleVPEGylated PLGA-based nanoparticles targeting M cells for oral vaccinationJ Control Release2007120319520417586081
   PubMed Web of Science ®Google Scholar
• LiuZHJiaoYPWangYFZhouCRZhangZYPolysaccharides-based nanoparticles as drug delivery systemsAdv Drug Deli Rev20086016501662
   PubMed Web of Science ®Google Scholar
• LemarchandCCouvreurPBesnardMCostantiniDGrefRNovel polyester-polysaccharide nanoparticlesPharm Res20032081284129212948027
   PubMed Web of Science ®Google Scholar
• RodriguesJSSantos-MagalhaesNSCoelhoLCCouvreurPPonchelGGrefRNovel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectinsJ Control Release2003921–210311214499189
   PubMed Web of Science ®Google Scholar
• LemarchandCGrefACouvreurPPolysaccharide-decorated nanoparticlesEur J Pharm Biopharm200458232734115296959
   PubMed Web of Science ®Google Scholar
• LemarchandCGrefRLesieurSPhysico-chemical characterization of polysaccharide-coated nanoparticlesJ Control Release200510819711116169626
   PubMed Web of Science ®Google Scholar
• YadavAKMishraPJainSMishraAKAgrawalGPPreparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicinJ Drug Target200816646447818604659
   PubMed Web of Science ®Google Scholar
• PitarresiGPalumboFSAlbaneseAFioricaCPiconePGiammonaGSelf-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drugJ Drug Target201018426427619939202
   PubMed Web of Science ®Google Scholar
• WildgruberMLeeHChudnovskiyAMonocyte subset dynamics in human atherosclerosis can be profiled with magnetic nanosensorsPLoS One200945e566319461894
   PubMed Web of Science ®Google Scholar
• DuYZWengQYuanHHuFQSynthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin deliveryACS Nano20104116894690220939508
   PubMed Web of Science ®Google Scholar
• PipitoneVRChondroprotection with chondroitin sulfateDrugs Exp Clin Res1991171371914834
   PubMedGoogle Scholar
• VolpiNChondroitin sulfate for the treatment of osteoarthritisCurr Med Chem Anti Inflamm Anti Allergy Agents200543221234
   Google Scholar
• WangLFShenSSLuSCSynthesis and characterization of chondroitin sulfate-methacrylate hydrogelsCarbohy Polym2003527389396
   Web of Science ®Google Scholar
• ChenALNiHCWangLFChenJSBiodegradable amphiphilic copolymers based on poly(epsilon-caprolactone)-graft chondroitin sulfate as drug carriersBiomacromolecules2008992447245718662028
   PubMed Web of Science ®Google Scholar
• WangLFNiHCLinCCChondroitin sulfate-g-poly(varepsilon-caprolactone) co-polymer aggregates as potential targeting drug carriersJ Biomater Sci Polym Ed9222011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
   PubMed Web of Science ®Google Scholar
• WangLLZhangZLiQEthanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementationHum Reprod200924356257919091803
   PubMed Web of Science ®Google Scholar
• AllenCMaysingerDEisenbergANano-engineering block copolymer aggregates for drug deliveryColloid Surf B Biointerfaces1999191–4327
   Web of Science ®Google Scholar
• BodnarMHartmannJFBorbelyJSynthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticlesBiomacromolecules20067113030303617096528
   PubMed Web of Science ®Google Scholar
• DuanKZhangXTangXFabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecinColloid Surf B Biointerfaces2010762475482
   PubMed Web of Science ®Google Scholar
• ShuaiXAiHNasongklaNKimSGaoJMicellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin deliveryJ Control Release200498341542615312997
   PubMed Web of Science ®Google Scholar
• BreunigMBauerSGoepferichAPolymers and nanoparticles: intelligent tools for intracellular targeting?Eur J Pharm Biopharm200868111212817804211
   PubMed Web of Science ®Google Scholar
• MohanPRapoportNDoxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear traffickingMol Pharm2010761959197320957997
   PubMed Web of Science ®Google Scholar
• NishiyamaNKataokaKNanostructured devices based on block copolymer assemblies for drug delivery: designing structures for enhanced drug functionAdv Polym Sci200619367101
   Web of Science ®Google Scholar
• XiongXBMaZLaiRLavasanifarAThe therapeutic response to mul-tifunctional polymeric nanoconjugates in the targeted cellular and sub-cellular delivery of doxorubicinBiomaterials201031475776819818492
   PubMed Web of Science ®Google Scholar
• MaedaHMatsumuraYEPR effect based drug design and clinical outlook for enhanced cancer chemotherapyAdv Drug Deliv Rev201163312913020457195
   PubMed Web of Science ®Google Scholar